The Unusual Situation With Testagen
Testagen is a synthetic tetrapeptide, Lys-Glu-Asp-Gly (KEDG), C17H29N5O9, 447.44 g/mol, classified within the bioregulator family as testicular-associated.
A PubMed search returns exactly one study whose title names Testagen. It is a 2025 paper in Molecules on the inhibitory effect and adsorption properties of Testagen peptide on copper surfaces in saline environments (Dobrițescu et al., PMID 40807317).
That is a corrosion-science paper. It is real, recent, peer-reviewed research on this exact molecule — and it has nothing to do with biology, testosterone, or testicular tissue.
Research use only. Supplied for laboratory research. Not for human or veterinary use. No marketing authorisation exists and no therapeutic claim is made.
Why This Distinction Matters
A citation count is not an evidence base. Anyone searching this compound will find a 2025 PubMed entry naming it and may reasonably assume biological work exists. It does not.
What the corrosion paper does establish is worth noting on its own terms: the peptide adsorbs to metal surfaces in saline. That is a statement about its physical chemistry — charge distribution and surface affinity — and it is the only experimentally verified property of this molecule in the published record.
What Is Not Established
No published study establishes an effect on testicular tissue, testosterone regulation, steroidogenesis, gene expression, or any biological endpoint. No safety profile. No amount for any species.
The class-level literature — peptide regulation of gene expression (PMID 34834147) — describes the family, not this compound. The testicular association is a classification within the family's own scheme.
What This Means for Research Design
Testagen cannot serve as a positive control or a benchmark: nothing about its biological behaviour has been published. It is a legitimate subject if the question is characterising an unstudied member of a family with a stated mechanistic hypothesis — and, unusually, its surface-chemistry behaviour is already documented, which may be useful in assay design where metal contact is a variable.
Structure and Handling
- Sequence. Lys-Glu-Asp-Gly (KEDG), tetrapeptide.
- Formula. C17H29N5O9, 447.44 g/mol.
- Form. Lyophilised powder, ≥98% purity, third-party certificate of analysis per batch.
- Storage. Sealed vial at −20 °C, protected from light; reconstituted solution at 2–8 °C.
- Reconstitution. Bacteriostatic water down the vial wall, never onto the powder cake. Do not shake. See the reconstitution calculator.
Better-Documented Alternatives
KEDG is KED plus glycine. Pancragen (KED + Trp) has six biological papers including primate work; Livagen (KED + Ala) has three. If compound-specific biological evidence matters to the design, those are the better starting points. Full family on the bioregulator overview.